Markets:

Overview

News

Currencies

International

Treasuries

Adverum Biotechnologies, Inc. - Common Stock (NQ:ADVM)

4.190 UNCHANGED

Streaming Delayed Price Updated: 9:41 AM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Adverum Biotechnologies, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

75 Biggest Movers From Friday ↗

July 26, 2021

Gainers The New Home Company Inc. (NYSE: NWHM) jumped 82.9% to settle at $8.89 on Friday after the company agreed to be acquired by funds managed by affiliates of Apollo Global...

Via Benzinga

Where Adverum Biotechnologies Stands With Analysts ↗

July 23, 2021

Analysts have provided the following ratings for Adverum Biotechnologies (NASDAQ:

Via Benzinga

50 Stocks Moving In Friday's Mid-Day Session ↗

July 23, 2021

Gainers Xenetic Biosciences Inc (NASDAQ: XBIO) shares jumped 111.3% to $3.9299 on abnormally-high volume. The New Home Company Inc. (NYSE: NWHM) climbed 83% to $8.90 after the...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 23, 2021 ↗

July 23, 2021

Upgrades Craig-Hallum upgraded the previous rating for Lindblad Expeditions Holdings Inc (NAS...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 23, 2021

Gainers Acorda Therapeutics (NASDAQ:ACOR) stock moved upwards by 56.69% to $5.97 during Friday's pre-market session. The market value of their outstanding shares is at...

Via Benzinga

10 Biggest Price Target Changes For Friday ↗

July 23, 2021

Keybanc raised the price target on Twitter, Inc. (NYSE: TWTR) from $77 to $81. Twitter shares rose 6.4% to $74.00 in pre-market trading. Baird boosted the price target for...

Via Benzinga

32 Stocks Moving in Friday's Pre-Market Session ↗

July 23, 2021

Gainers Socket Mobile Inc (NASDAQ: SCKT) shares rose 100.2% to $11.61 in pre-market trading after the company reported better-than-expected Q2 results. Acorda Therapeutics Inc (...

Via Benzinga

The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs ↗

July 23, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22) Bio-Techne Corporation (...

Via Benzinga

Adverum Stock Falls As It Stops Testing Ocular Gene Therapy Candidate In Diabetic Macular Edema Patients ↗

July 23, 2021

Adverum Biotechnologies Inc (NASDAQ: ADVM) has decided to drop the development of ADVM-022 intravitreal (IVT) injection gene therapy in diabetic macular edema (DME...

Via Benzinga

Understanding Adverum Biotechnologies's Unusual Options Activity ↗

July 19, 2021

Shares of Adverum Biotechnologies (NASDAQ:ADVM) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved down to $3. Sentiment:...

Via Benzinga

The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street ↗

July 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated...

Via Benzinga

The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study ↗

July 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) IVERIC bio, Inc. (NASDAQ:...

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs ↗

July 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,...

Via Benzinga

Topics Product Recall

The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test ↗

July 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:...

Via Benzinga

Topics Product Recall

Why Adverum Biotechnologies Stock Sank in May ↗

June 07, 2021

The uncertainty over the biotech's lead clinical asset weighed on its shares last month.

Via The Motley Fool

The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal ↗

May 25, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24) Bristol-Myers Squibb Company...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

May 24, 2021

Monday morning saw 11 companies set new 52-week lows. Facts of Interest: The largest company by market cap to set a new 52-week low was TAL Education (NYSE:TAL). Meten...

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Order Flow Abounds, Voyager CEO, CMO To Depart, Decision Day For Bristol-Myers Squibb, ASCO Abstracts Move Stocks ↗

May 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 19) ESSA Pharma Inc. (NASDAQ:...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

May 19, 2021

On Wednesday morning, 19 companies hit new 52-week lows. Significant Points: Canadian Pacific Railway (NYSE:CP) was the largest company by market cap to set a new 52-week...

Via Benzinga

The Sonic Fund II, L.P. Comments on Preliminary Voting Results of Adverum Annual Meeting

May 12, 2021

From The Sonic Fund II, L.P.

Via Business Wire

Unusual Options Activity Insight: Adverum Biotechnologies ↗

May 12, 2021

Shares of Adverum Biotechnologies (NASDAQ:ADVM) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved up to $3.94. Sentiment...

Via Benzinga

The Sonic Fund II, L.P. Issues Statement to Adverum Stockholders

May 11, 2021

From The Sonic Fund II, L.P.

Via Business Wire

The Sonic Fund II, L.P. Reminds Adverum Stockholders to Vote for Its Three Independent Director Nominees at May 12 Annual Meeting

May 10, 2021

From The Sonic Fund II, L.P.

Via Business Wire

Glass Lewis Joins ISS In Recommending Adverum Shareholders Vote for All Three Independent Sonic Director Nominees

May 06, 2021

From The Sonic Fund II, L.P.

Via Business Wire

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗

May 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗

May 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

ISS Recommends Adverum Stockholders Vote to Elect Sonic’s Three Independent, Highly Qualified Nominees

May 04, 2021

From The Sonic Fund II, L.P.

Via Business Wire

The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data ↗

May 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

22 Stocks Moving in Monday's Pre-Market Session ↗

May 03, 2021

Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) rose 58.3% to $78.90 in pre-market trading. Nicholas Jason Singer disclosed a 9.13% passive stake in Brooklyn...

Via Benzinga

Adverum's Wet AMD Gene Therapy Shows Long Term Benefit In Treatment-Experienced Patients ↗

May 03, 2021

Adverum Biotechnologies Inc (NASDAQ: ADVM) has announced new long-term data from the OPTIC Phase 1 trial of ADVM-022 single intravitreal (IVT) injection gene...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.